COVID-19 in Arapongas city – State of Paraná – Brazil

Evolution and effects of vaccination between March 2020 and June 2023

Authors

  • Moacir Paludetto Junior Secretaria Municipal de Saúde, Arapongas, Brasil
  • André Silva Olak Departamento de Arquitetura e Urbanismo - Universidade Estadual de Londrina (UEL)
  • Aline Midori Susuki Departamento de Arquitetura e Urbanismo - Universidade Estadual de Londrina (UEL)
  • Fernando Marques De Marcos Secretaria Municipal de Saúde, Arapongas, Brasil
  • Priscila Andressa Catenace da Costa Secretaria Municipal de Saúde, Arapongas, Brasil
  • Fernanda Golas Trombini Secretaria Municipal de Saúde, Arapongas, Brasil
  • Rodrigo Rossetto Pescim Departamento de Estatística - Universidade Estadual de Londrina (UEL)
  • Carlos Alberto de Oliveira Departamento de Estruturas - Universidade Estadual de Londrina (UEL)
  • Mariana Ragassi Urbano Departamento de Estatística - Universidade Estadual de Londrina (UEL)

Keywords:

Arapongas, COVID-19, Pandemic, Public-institutional partnership, Vaccination

Abstract

The COVID-19 pandemic, caused by the SARS-CoV-2 virus, had strong impacts that go beyond the health aspect. This research was carried out with COVID-19 data from Arapongas - PR, Brazil. Between March 2020 and June 2023, 41305 cases and 644 deaths by COVID-19 were recorded. In the first half of 2021, the lethality rate for the period was 2.91%, and in the first half of 2023, the rate was 0.31%. The reduction in the lethality rate coincided with the increase in vaccination rates, since, by June 2023, 93.17% of the population had received at least one dose of the vaccine and 84.73% the second dose or single dose. If the lethality rate had remained at the level recorded until the first half of 2021, the city would have recorded 426 more deaths from COVID-19, reaching 1070 deaths, an increase of 66.15%. Despite hesitancy fueled by misinformation and social media, the vaccination campaign (COVID-19) was highly effective. Of the 644 deaths related to COVID-19, 73.9% were unvaccinated. No deaths were recorded among individuals under 60 years of age who received the fourth dose, 2nd booster or bivalent vaccine, and for individuals aged 60 or over, five deaths were recorded among those who received the fourth dose or 2nd booster, and no deaths for those who received the bivalent vaccine. The conclusions affirm the potential of vaccines to save lives and the need for ongoing public health initiatives to prevent and treat diseases, carry out vaccination campaigns and combat fake news.

References

BOTEGA, L.A.; ANDRADE, M.V.; GUEDES, G.R. Brazilian hospitals’ performance: an assessment of the unified health system (SUS). Health Care Management Science, v. 23, p. 443-452, 2020.

CORREA-GALENDI, J.S.; DIZ, M.P.E.; STOCK, S.; MÜLLER, D. Economic modelling of screenand-treat strategies for Brazilian women at risk of hereditary breast and ovarian cancer. Appl Health Econ Health Policy, v. 19, p. 97-109, 2021.

DOMINGUES, C.M.A.S; TEIXEIRA, A.M.S. Coberturas vacinais e doenças imunopreveníveis no Brasil no período 1982-2012: avanços e desafios do Programa Nacional de Imunizações. Epidemiol Serv Saude, v. 22, p. 9-27, 2013.

DUBÉ, E.; VIVION, M.; MACDONALD NE. Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications. Expert Rev Vaccines, v. 14, p. 99-117, 2015.

IBGE - Instituto Brasileiro de Geografia e Estatística. Cidades e Estados. Rio de Janeiro: IBGE, 2023. Available from: https://shorturl.at/cjpG1. Acess in: 28 August. 2023.

FAJAR, J.K.; SALLAM, M.; SOEGIARTO, G.; SUGIRI, Y.J.; ANSHORY, M.; WULANDARI, L.; KOSASIH, S.A.P.; ILMAWAN, M.; KUSNAENI, K.; FIKRI, M.; et al. Global Prevalence and Potential Influencing Factors of COVID-19 Vaccination Hesitancy: A Meta-Analysis. Vaccines , v. 10, p. 1-20, 2022.

GALHARDI, C.P.; FREIRE, N.P.; FAGUNDES, M.C.M.; MINAYO, M.C.S.; CUNHA, I.C.K. Fake News and vaccine hesitancy in the COVID-19 pandemic in Brazil, v. 27, p. 1849-1858, 2022.

OLAK, A.S.; SANTOS, W.S.; SUSUKI, A.M.; POTT-JUNIOR, H.; V. SKALNY, A.; TINKOV, A.A.; ASCHNER, M.; PINESE, J.P.P.; URBANO, M.R.; PAOLIELLO, M.M.B. Meteorological parameters and cases of COVID-19 in Brazilian cities: an observational study. Journal of Toxicology and Environmental Health - Part A - Current Issues, v. 1, p. 1-15, 2021.

OLAK, A.S.; SUSUKI, A.M.; KANASHIRO, M.; PAOLIELLO, M.M.B.; ASCHNER, M.; URBANO, M.R. Risk factors associated with COVID-19-induced death in patients hospitalized in intensive care units (ICUs) in a city in Southern Brazil. Toxicology Reports, v. 8, p. 1565-1568, 2021.

PALUDETTO JUNIOR, M.; OLAK, A.S.; PASSARELLI-ARAUJO, H.; SUSUKI, A.M.; ASCHNER, M.; POTT-JUNIOR, H.; PAOLIELLO, M.M.B.; URBANO, M.R. COVID-19 vaccination and case fatality rates: a case report in a Brazilian municipality. Reports in Public Health, v. 39, p. 1-12, 2023.

PASSARELLI-ARAUJO, H.; PASSARELLI-ARAUJO, H.; URBANO, M.R. ; PESCIM, R.R. Machine learning and comorbidity network analysis for hospitalized patients with COVID-19 in a city in Southern Brazil. Smart Health, v. 26, p. 1-10, 2022a.

PASSARELLI-ARAUJO, H.; PASSARELLI-ARAUJO, H.; PESCIM, R.R.; OLAK, A.S. ; SUSUKI, A.M.; TOMIMATSU, M.F.A.I. ; VOLCE, C.J. ; NEVES, M.A.Z. ; SILVA, F.F. ; NARCISO, S.G. ; PAOLIELLO, M.M.B.; POTT-JUNIOR, H.; URBANO, M.R. Probabilistic survival modeling in health research: an assessment using cohort data from hospitalized patients with COVID-19 in a Latin American city. Journal Of Toxicology and Environmental Health - Part A - Current Issues, v. 1, p. 1-13, 2023.

PASSARELLI-ARAUJO, H.; POTT-JUNIOR, H.; SUSUKI, A.M.; OLAK, A.S.; PESCIM, R.R.; TOMIMATSU, M.F.A.I.; VOLCE, C.J.; NEVES, M.A.Z.; SILVA, F.F.; NARCISO, S.G.; ASCHNER, M.; PAOLIELLO, M.M.B.; URBANO, M.R. . The impact of COVID-19 vaccination on case fatality rates in a city in Southern Brazil. American Journal of Infection Control, v. 1, p. 491-496, 2022b.

PNOVCC - Plano Nacional De Operacionalização Da Vacinação Contra COVID-19. Brasília: Ministério da Saúde, 2020. 1ª Edição. Available from: https://shorturl.at/mFSU2. Acess in: 28 August. 2023.

PNOVCC - Plano Nacional De Operacionalização Da Vacinação Contra COVID-19. Brasília: Ministério da Saúde, 2022. 13ª Edição. Available from: https://shorturl.at/citBT. Acess in: 28 August. 2023.

R CORE TEAM. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2023. ISBN 3-900051-07-0, Available from: http://www.R-project.org/.

RODRIGUEZ-MORALES, A.; GALLEGO, V.; ESCALERA-ANTEZANA, J.; MENDEZ, C.; ZAMBRANO, L.; FRANCO-PAREDES, C.; RISQUEZ, A. COVID-19 in Latin America: The implications of the first confirmed case in Brazil. Travel Med Infect Dis, v. 35, p. 1-3, 2020.

SATO, A.P.S. What is the importance of vaccine hesitancy in the drop of vaccination coverage in Brazil ? Revista De Saúde Pública, v. 52, p. 1-9, 2018.

SUSUKI, A.M.; OLAK, A.S. ; LEAO, A.L.F. ; KANASHIRO, M. ; URBANO, M. R. . Evolution of COVID-19 in Londrina (State of Paraná - Brazil) between March and August of 2020. Semina. Ciências Exatas E Tecnológicas (Online), v. 42, p. 5-16, 2021.

ZHU, N.; WANG, W.; LIU, Z. et al. Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells. Nature Communications, v. 11, p. 1-8, 2020.

Downloads

Published

06-01-2024

How to Cite

Paludetto Junior, M. ., Silva Olak, A. ., Midori Susuki, A. ., Marques De Marcos, F. ., Catenace da Costa, P. A. ., Trombini , F. G. ., … Ragassi Urbano, M. (2024). COVID-19 in Arapongas city – State of Paraná – Brazil: Evolution and effects of vaccination between March 2020 and June 2023. Sigmae, 12(3), 201–212. Retrieved from https://publicacoes.unifal-mg.edu.br/revistas/index.php/sigmae/article/view/2236